Phytomedicines Used for Diabetes Mellitus in Ghana: A Systematic Search and Review of Preclinical and Clinical Evidence

被引:25
|
作者
Adinortey, Michael Buenor [1 ]
Agbeko, Rosemary [2 ]
Boison, Daniel [1 ]
Ekloh, William [1 ,3 ]
Kuatsienu, Lydia Enyonam [4 ]
Biney, Emmanuel Ekow [1 ]
Affum, Obed O. [1 ]
Kwarteng, Jeffery [1 ]
Nyarko, Alexander Kwadwo [5 ]
机构
[1] Univ Cape Coast, Sch Biol Sci, Dept Biochem, Cape Coast, Ghana
[2] Univ Cape Coast, Sch Biol Sci, Dept Mol Biol & Biotechnol, Cape Coast, Ghana
[3] Univ Ghana, Dept Biochem Cell & Mol Biol, West Africa Ctr Cell Biol Infect Dis & Pathogens, Legon, Ghana
[4] Princefield Univ Coll, Sch Pharm, Dept Pharmacol, Ho, Ghana
[5] Univ Ghana, Sch Pharm, Dept Pharmacol & Toxicol, Legon, Ghana
关键词
COSTUS-AFER; LEAVES EXTRACT; STREPTOZOTOCIN; GLUCOSE; LEAF; STEM;
D O I
10.1155/2019/6021209
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. Available data indicate that diabetes mellitus leads to elevated cost of healthcare. This imposes a huge economic burden on households, societies, and nations. As a result many Ghanaians, especially rural folks, resort to the use of phytomedicine, which is relatively less expensive. This paper aims at obtaining information on plants used in Ghana to treat diabetes mellitus, gather and present evidence-based data available to support their uses and their mechanisms of action, and identify areas for future research. Method. A catalogue of published textbooks, monographs, theses, and peer-reviewed articles of plants used in Ghanaian traditional medicine between 1987 and July 2018 for managing diabetes mellitus was obtained and used. Results. The review identified 76 plant species belonging to 45 families that are used to manage diabetes mellitus. Leaves were the part of the plants frequently used for most preparation (63.8%) and were mostly used as decoctions. Majority of the plants belonged to the Euphorbiaceae, Lamiaceae, Asteraceae, and Apocynaceae families. Pharmacological data were available on 23 species that have undergone in vitro studies. Forty species have been studied using in vivo animal models. Only twelve plants and their bioactive compounds were found with data on both preclinical and clinical studies. The records further indicate that medicinal plants showing antidiabetic effects did so via biochemical mechanisms such as restitution of pancreatic -cell function, improvement in insulin sensitivity by receptors, stimulating rate of insulin secretion, inhibition of liver gluconeogenesis, enhanced glucose absorption, and inhibition of G-6-Pase, -amylase, and -glucosidase activities. Conclusion. This review contains information on medicinal plants used to manage diabetes mellitus, including their pharmacological properties and mechanisms of action as well as models used to investigate them. It also provides gaps that can form the basis for further investigations and development into useful medications for effective treatment of diabetes mellitus.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] SYSTEMATIC REVIEW OF CLINICAL PRACTICE GUIDELINES ON THE PHARMACOLOGIC TREATMENT OF TYPE 2 DIABETES MELLITUS: ARE GUIDELINES EVIDENCE-BASED?
    Bennett, Wendy L.
    Odelola, Olaide
    Wilson, Lisa
    Bolen, Shari
    Bass, Eric B.
    Dalal, Deepan
    Puhan, Milo
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S70 - S71
  • [32] SYSTEMATIC REVIEW OF THE COST EFFECTIVENESS OF DAPAGLIFLOZIN USED TO TREAT PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Tsan, J.
    Duong, T.
    Girgis, N.
    Labib, M.
    Moustakas, A.
    Loh, F. E.
    VALUE IN HEALTH, 2018, 21 : S75 - S75
  • [33] Quality of the evidence on barriers to medication adherence in patients with diabetes mellitus: a systematic review of systematic reviews.
    Awaisu, Ahmed
    Jaam, Myriam
    Izham, Mohamed
    Kheir, Nadir
    PHARMACOTHERAPY, 2016, 36 (12): : E298 - E299
  • [34] Efficacy, safety and phytochemistry of medicinal plants used for the management of diabetes mellitus in Ethiopia: a systematic review
    Serawit Deyno
    Kassahun Eneyew
    Sisay Seyfe
    Elias Wondim
    Clinical Phytoscience, 7 (1)
  • [35] Deep brain stimulation for opioid use disorder: A systematic review of preclinical and clinical evidence
    Fattahi, Mojdeh
    Eskandari, Kiarash
    Sayehmiri, Fatemeh
    Kuhn, Jens
    Haghparast, Abbas
    BRAIN RESEARCH BULLETIN, 2022, 187 : 39 - 48
  • [36] Systematic review of preclinical, clinical, and post-marketing evidence of bupropion misuse potential
    Naglich, Andrew C.
    Brown, E. Sherwood
    Adinoff, Bryon
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 341 - 354
  • [37] Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
    Mirabile, Aurora
    Rivoltini, Licia
    Daveri, Elena
    Vernieri, Claudio
    Mele, Roberto
    Porcu, Luca
    Lazzari, Chiara
    Bulotta, Alessandra
    Vigano, Maria Grazia
    Cascinu, Stefano
    Gregorc, Vanesa
    CANCERS, 2020, 12 (05)
  • [38] Is there an evidence base for the clinical features used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
    Shields, B. M.
    Peters, J. L.
    Cooper, C.
    Lowe, J.
    Knight, B.
    Powell, R.
    Hyde, C. J.
    Hattersley, A. T.
    DIABETOLOGIA, 2014, 57 : S439 - S440
  • [39] Oxymel: A systematic review of preclinical and clinical studies
    Darani, Narges Sharifi
    Vaghasloo, Mahdi Alizadeh
    Kazemi, Asma
    Amri, Hakima
    Rampp, Thomas
    Hashempur, Mohammad Hashem
    HELIYON, 2023, 9 (12)
  • [40] Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature
    Nalysnyk, L.
    Hernandez-Medina, M.
    Krishnarajah, G.
    DIABETES OBESITY & METABOLISM, 2010, 12 (04): : 288 - 298